Cart summary

You have no items in your shopping cart.

Pantoprazole sodium hydrate

SKU: orb1225998

Description

A proton pump inhibitor that inhibits gastric acid secretion; works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid; inhibits autophagy and increases the toxicity of docetaxel in vitro and in vivo.Ulcer Approved.

Images & Validation

Key Properties

CAS Number164579-32-2
MW433.38
Purity>98% (HPLC)
FormulaC16H15F2N3O4S . 3/2H2 O . Na
SMILESO.O.O.[Na+].[Na+].COC1=C(OC)C(CS(=O)C2=NC3=C([N-]2)C=CC(OC(F)F)=C3)=NC=C1.COC1=C(OC)C(CS(=O)C2=NC3=C([N-]2)C=CC(OC(F)F)=C3)=NC=C1
TargetProton Pump
Solubility10 mM in H2O

Bioactivity

In Vivo
Pantoprazole sodium hydrate (BY1023 sodium hydrate; 200 mg/kg; IP; once a week for 3 weeks) significantly increases tumor growth delay of MCF-7 xenografts combined with Doxorubicin. Pantoprazole sodium hydrate (0.3-3 mg/kg, p.o.) dose-dependently decreases both basal acid secretion in pylorus-ligated rats and the stimulated acid secretion induced by mepirizole in acute fistula rats. Animal model: Mice bearing MCF-7 or A431 xenografts. Dosage: 200 mg/kg. Administration: IP; once a week for 3 weeks; alone or 2 hours before Doxorubicin (6 mg/kg i. v.). Result: Showed even greater growth delay of MCF-7 xenografts with Doxorubicin compared with the single-dose combination. Significantly increased tumor growth delay with a single dose with Doxorubicin.
In Vitro
Pantoprazole sodium hydrate (BY1023 sodium hydrate; 1-10000 μM) leads to concentration-dependent increases in endosomal pH in EMT-6 and MCF7 cells. Pantoprazole sodium hydrate can block exosome release. Pantoprazole sodium hydrate inhibits the activity of V-H+-ATPase and impaires the ability of tumour cells (melanomas, adenocarcinomas, and lymphoma cell lines) to acidify the extracellular medium.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

SKF-96022 sodium hydrate

Similar Products

  • Pantoprazole Sodium Hydrate [orb1710745]

    98.32% (May vary between batches)

    164579-32-2

    432.37

    C16H14F2N3NaO4S·3/2H2O

    1 g, 500 mg, 100 mg
  • Pantoprazole sodium hydrate [orb611376]

    >98%

    164579-32-2

    433.38

    C16H15F2N3O4S . 3/2H2 O . Na

    1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Pantoprazole sodium hydrate (orb1225998)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

50 mg
$ 70.00
100 mg
$ 90.00
200 mg
$ 130.00
500 mg
$ 220.00